- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
- POS EX Additional exhibits for listing
- 99 Terms and Conditions of the Automatic Dividend Reinvestment Plan
- 99 Underwriting Agreement
- 99 Specimen Dealer Letter Agreement
- 99 Specimen Nuveen Master Selected Dealer Agreement
- 99 Specimen Morgan Stanley & Co. LLC Master Selected Dealers Agreement
- 99 Specimen Morgan Stanley & Co. LLC Master Agreement Among Underwriters
- 99 Morgan Stanley & Co. LLC Structuring and Syndication Fee Agreement
- 99 Wells Fargo Securities, LLC Structuring Fee Agreement
- 99 Ameriprise Financial Services, Inc. Fee Agreement
- 99 BB&T Capital Markets, a Division of BB&T Securities, LLC Fee Agreement
- 99 D.a. Davidson & Co. Fee Agreement
- 99 RBC Capital Markets, LLC Fee Agreement
- 99 Stifel, Nicolaus & Company, Incorporated Fee Agreement
- 99 Wedbush Securities Inc. Fee Agreement
- 99 Consent of Stradley Ronon Stevens & Young, LLP
- 99 Consent of Morgan, Lewis & Bockius LLP
- 99 Consent of KPMG LLP
- 99 Powers of Attorney
exhibit l.4
December 20, 2018
Stradley Ronon Stevens & Young, LLP
191 N. Wacker Dr., Ste. 1601
Chicago, Illinois 60606
RE: Nuveen High Income 2023 Target Term Fund
Ladies and Gentlemen:
As special Massachusetts counsel to Nuveen High Income 2023 Target Term Fund, a Massachusetts business trust (the “Fund”), we consent to the incorporation by reference of our opinion filed with the Securities and Exchange Commission in the Registration Statement filed pursuant to Rule 462(b) on FormN-2 (File Nos.333-228884 and811-23381) on November 18, 2018.
In giving this consent, we do not concede that we are in the category of persons whose consent is required under Section 7 of the Securities Act of 1933, as amended.
Very truly yours,
/s/ Morgan, Lewis & Bockius LLP
MORGAN, LEWIS & BOCKIUS LLP